Prognosis of T3N0M0 small-cell non-anaplastic bronchogenic carcinoma

We analyzed the survival after surgery for non-small cell lung cancer (NSCLC) classified as T3N0. Between January 1969 and 1995, 151 patients underwent surgery for NSCLC in our hospital. Survival analysis was performed using the Kaplan-Meier statistical method and the curves were compared using Mant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archivos de bronconeumología 2000-10, Vol.36 (9), p.510-514
Hauptverfasser: Calvo Medina, V, Padilla Alarcón, J, García Zarza, A, Pastor Guillem, J, Blasco Armengod, E, París Romeu, F
Format: Artikel
Sprache:spa
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 514
container_issue 9
container_start_page 510
container_title Archivos de bronconeumología
container_volume 36
creator Calvo Medina, V
Padilla Alarcón, J
García Zarza, A
Pastor Guillem, J
Blasco Armengod, E
París Romeu, F
description We analyzed the survival after surgery for non-small cell lung cancer (NSCLC) classified as T3N0. Between January 1969 and 1995, 151 patients underwent surgery for NSCLC in our hospital. Survival analysis was performed using the Kaplan-Meier statistical method and the curves were compared using Mantel-Cox, Breslow and Tarone-Ware tests. The estimated five-year survival in the studied population was 44.46 +/- 4.30%. Four groups were defined based on degree of tumoral invasion of mediastinal structures, parietal pleura, chest wall or superior sulcus. Significant differences in five-year survival were observed between groups. Patients in the mediastinal group (59.98 +/- 8.71%) had the best prognosis, followed by patients with parietal pleura involvement (52.79 +/- 6.69%). Survival in the chest wall group was 27.53 +/- 7.22%. No patients with superior sulcus tumors survived over five years (median survival 1.50 +/- 1.16 years; 95% confidence interval 0.00 to 3.77 years). Prognosis is clearly determined by degree of tumoral invasion in T3N0 patients. In spite of the evident conceptual improvements achieved with the revised International Staging System, the system still fails to fully define prognosis in such cases.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72486796</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72486796</sourcerecordid><originalsourceid>FETCH-LOGICAL-p547-a0172cfb753096e6685ef62afaad3f897245ecb77b7110e1e1d6b025625981773</originalsourceid><addsrcrecordid>eNo1TztPwzAY9ACipfAXUCY2S37EdjKi8qpUHkP26LNjlyDHDnYz8O8xotxyOul0jzO0JpwQzJpWrtBlzp-EMMFrdoFWtECKWq3R_XuKhxDzmKvoqo6_khdS5Qm8x8Z6X4UYMASYPeTjaCqdYjAf8WBDEQaSGUOc4AqdO_DZXp94g7rHh277jPdvT7vt3R7PpQsDoYoZp5XgpJVWykZYJxk4gIG7plWsFtZopbSilFhq6SB1mSyZaBuqFN-g27_YOcWvxeZjP435dyUEG5fcl4BGqlYW483JuOjJDv2cxgnSd_9_m_8A8NJRdw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72486796</pqid></control><display><type>article</type><title>Prognosis of T3N0M0 small-cell non-anaplastic bronchogenic carcinoma</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Calvo Medina, V ; Padilla Alarcón, J ; García Zarza, A ; Pastor Guillem, J ; Blasco Armengod, E ; París Romeu, F</creator><creatorcontrib>Calvo Medina, V ; Padilla Alarcón, J ; García Zarza, A ; Pastor Guillem, J ; Blasco Armengod, E ; París Romeu, F</creatorcontrib><description>We analyzed the survival after surgery for non-small cell lung cancer (NSCLC) classified as T3N0. Between January 1969 and 1995, 151 patients underwent surgery for NSCLC in our hospital. Survival analysis was performed using the Kaplan-Meier statistical method and the curves were compared using Mantel-Cox, Breslow and Tarone-Ware tests. The estimated five-year survival in the studied population was 44.46 +/- 4.30%. Four groups were defined based on degree of tumoral invasion of mediastinal structures, parietal pleura, chest wall or superior sulcus. Significant differences in five-year survival were observed between groups. Patients in the mediastinal group (59.98 +/- 8.71%) had the best prognosis, followed by patients with parietal pleura involvement (52.79 +/- 6.69%). Survival in the chest wall group was 27.53 +/- 7.22%. No patients with superior sulcus tumors survived over five years (median survival 1.50 +/- 1.16 years; 95% confidence interval 0.00 to 3.77 years). Prognosis is clearly determined by degree of tumoral invasion in T3N0 patients. In spite of the evident conceptual improvements achieved with the revised International Staging System, the system still fails to fully define prognosis in such cases.</description><identifier>ISSN: 0300-2896</identifier><identifier>PMID: 11116547</identifier><language>spa</language><publisher>Spain</publisher><subject>Carcinoma, Bronchogenic - mortality ; Carcinoma, Bronchogenic - pathology ; Carcinoma, Bronchogenic - surgery ; Carcinoma, Small Cell - mortality ; Carcinoma, Small Cell - pathology ; Carcinoma, Small Cell - surgery ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Prospective Studies ; Survival Analysis</subject><ispartof>Archivos de bronconeumología, 2000-10, Vol.36 (9), p.510-514</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11116547$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Calvo Medina, V</creatorcontrib><creatorcontrib>Padilla Alarcón, J</creatorcontrib><creatorcontrib>García Zarza, A</creatorcontrib><creatorcontrib>Pastor Guillem, J</creatorcontrib><creatorcontrib>Blasco Armengod, E</creatorcontrib><creatorcontrib>París Romeu, F</creatorcontrib><title>Prognosis of T3N0M0 small-cell non-anaplastic bronchogenic carcinoma</title><title>Archivos de bronconeumología</title><addtitle>Arch Bronconeumol</addtitle><description>We analyzed the survival after surgery for non-small cell lung cancer (NSCLC) classified as T3N0. Between January 1969 and 1995, 151 patients underwent surgery for NSCLC in our hospital. Survival analysis was performed using the Kaplan-Meier statistical method and the curves were compared using Mantel-Cox, Breslow and Tarone-Ware tests. The estimated five-year survival in the studied population was 44.46 +/- 4.30%. Four groups were defined based on degree of tumoral invasion of mediastinal structures, parietal pleura, chest wall or superior sulcus. Significant differences in five-year survival were observed between groups. Patients in the mediastinal group (59.98 +/- 8.71%) had the best prognosis, followed by patients with parietal pleura involvement (52.79 +/- 6.69%). Survival in the chest wall group was 27.53 +/- 7.22%. No patients with superior sulcus tumors survived over five years (median survival 1.50 +/- 1.16 years; 95% confidence interval 0.00 to 3.77 years). Prognosis is clearly determined by degree of tumoral invasion in T3N0 patients. In spite of the evident conceptual improvements achieved with the revised International Staging System, the system still fails to fully define prognosis in such cases.</description><subject>Carcinoma, Bronchogenic - mortality</subject><subject>Carcinoma, Bronchogenic - pathology</subject><subject>Carcinoma, Bronchogenic - surgery</subject><subject>Carcinoma, Small Cell - mortality</subject><subject>Carcinoma, Small Cell - pathology</subject><subject>Carcinoma, Small Cell - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Survival Analysis</subject><issn>0300-2896</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1TztPwzAY9ACipfAXUCY2S37EdjKi8qpUHkP26LNjlyDHDnYz8O8xotxyOul0jzO0JpwQzJpWrtBlzp-EMMFrdoFWtECKWq3R_XuKhxDzmKvoqo6_khdS5Qm8x8Z6X4UYMASYPeTjaCqdYjAf8WBDEQaSGUOc4AqdO_DZXp94g7rHh277jPdvT7vt3R7PpQsDoYoZp5XgpJVWykZYJxk4gIG7plWsFtZopbSilFhq6SB1mSyZaBuqFN-g27_YOcWvxeZjP435dyUEG5fcl4BGqlYW483JuOjJDv2cxgnSd_9_m_8A8NJRdw</recordid><startdate>200010</startdate><enddate>200010</enddate><creator>Calvo Medina, V</creator><creator>Padilla Alarcón, J</creator><creator>García Zarza, A</creator><creator>Pastor Guillem, J</creator><creator>Blasco Armengod, E</creator><creator>París Romeu, F</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200010</creationdate><title>Prognosis of T3N0M0 small-cell non-anaplastic bronchogenic carcinoma</title><author>Calvo Medina, V ; Padilla Alarcón, J ; García Zarza, A ; Pastor Guillem, J ; Blasco Armengod, E ; París Romeu, F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p547-a0172cfb753096e6685ef62afaad3f897245ecb77b7110e1e1d6b025625981773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2000</creationdate><topic>Carcinoma, Bronchogenic - mortality</topic><topic>Carcinoma, Bronchogenic - pathology</topic><topic>Carcinoma, Bronchogenic - surgery</topic><topic>Carcinoma, Small Cell - mortality</topic><topic>Carcinoma, Small Cell - pathology</topic><topic>Carcinoma, Small Cell - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Calvo Medina, V</creatorcontrib><creatorcontrib>Padilla Alarcón, J</creatorcontrib><creatorcontrib>García Zarza, A</creatorcontrib><creatorcontrib>Pastor Guillem, J</creatorcontrib><creatorcontrib>Blasco Armengod, E</creatorcontrib><creatorcontrib>París Romeu, F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Archivos de bronconeumología</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Calvo Medina, V</au><au>Padilla Alarcón, J</au><au>García Zarza, A</au><au>Pastor Guillem, J</au><au>Blasco Armengod, E</au><au>París Romeu, F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognosis of T3N0M0 small-cell non-anaplastic bronchogenic carcinoma</atitle><jtitle>Archivos de bronconeumología</jtitle><addtitle>Arch Bronconeumol</addtitle><date>2000-10</date><risdate>2000</risdate><volume>36</volume><issue>9</issue><spage>510</spage><epage>514</epage><pages>510-514</pages><issn>0300-2896</issn><abstract>We analyzed the survival after surgery for non-small cell lung cancer (NSCLC) classified as T3N0. Between January 1969 and 1995, 151 patients underwent surgery for NSCLC in our hospital. Survival analysis was performed using the Kaplan-Meier statistical method and the curves were compared using Mantel-Cox, Breslow and Tarone-Ware tests. The estimated five-year survival in the studied population was 44.46 +/- 4.30%. Four groups were defined based on degree of tumoral invasion of mediastinal structures, parietal pleura, chest wall or superior sulcus. Significant differences in five-year survival were observed between groups. Patients in the mediastinal group (59.98 +/- 8.71%) had the best prognosis, followed by patients with parietal pleura involvement (52.79 +/- 6.69%). Survival in the chest wall group was 27.53 +/- 7.22%. No patients with superior sulcus tumors survived over five years (median survival 1.50 +/- 1.16 years; 95% confidence interval 0.00 to 3.77 years). Prognosis is clearly determined by degree of tumoral invasion in T3N0 patients. In spite of the evident conceptual improvements achieved with the revised International Staging System, the system still fails to fully define prognosis in such cases.</abstract><cop>Spain</cop><pmid>11116547</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-2896
ispartof Archivos de bronconeumología, 2000-10, Vol.36 (9), p.510-514
issn 0300-2896
language spa
recordid cdi_proquest_miscellaneous_72486796
source MEDLINE; Elsevier ScienceDirect Journals
subjects Carcinoma, Bronchogenic - mortality
Carcinoma, Bronchogenic - pathology
Carcinoma, Bronchogenic - surgery
Carcinoma, Small Cell - mortality
Carcinoma, Small Cell - pathology
Carcinoma, Small Cell - surgery
Female
Humans
Male
Middle Aged
Neoplasm Staging
Prognosis
Prospective Studies
Survival Analysis
title Prognosis of T3N0M0 small-cell non-anaplastic bronchogenic carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T13%3A39%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognosis%20of%20T3N0M0%20small-cell%20non-anaplastic%20bronchogenic%20carcinoma&rft.jtitle=Archivos%20de%20bronconeumolog%C3%ADa&rft.au=Calvo%20Medina,%20V&rft.date=2000-10&rft.volume=36&rft.issue=9&rft.spage=510&rft.epage=514&rft.pages=510-514&rft.issn=0300-2896&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72486796%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72486796&rft_id=info:pmid/11116547&rfr_iscdi=true